back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-28 08:48 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+6,438 vol |
52,730 | |
| Filed 2024-03-25 08:03 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+440 vol |
49,814 | |
| Filed 2024-03-25 08:01 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+1,444 vol |
49,374 | |
| Filed 2024-03-25 07:58 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,521 vol |
44,408 | |
| Filed 2024-03-25 07:56 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-7,043 vol |
40,887 | |
| Filed 2023-06-11 17:33 Tx date 2023-06-09 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,000 vol |
47,930 | |
| Filed 2023-06-07 20:46 Tx date 2023-06-06 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,000 vol |
46,930 | |
| Filed 2023-03-31 17:59 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+7,219 vol |
45,930 | |
| Filed 2023-03-31 17:39 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+6,012 vol |
38,711 | |
| Filed 2023-03-31 17:38 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-12,024 vol |
32,699 | |
| Filed 2023-03-27 09:42 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+137 vol |
44,723 | |
| Filed 2023-03-27 09:37 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+1,162 vol |
44,586 | |
| Filed 2022-04-03 18:40 Tx date 2022-03-31 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+5,721 vol |
43,424 | |
| Filed 2022-03-16 15:08 Tx date 2021-12-31 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+858 vol |
37,703 | |
| Filed 2021-03-19 17:30 Tx date 2021-03-19 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+6,825 vol |
36,845 | |
| Filed 2021-03-10 17:12 Tx date 2020-12-31 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+601 vol |
30,020 | |
| Filed 2020-06-26 16:35 Tx date 2020-06-24 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,000 vol |
29,419 | |
| Filed 2020-04-03 10:27 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+11,891 vol |
28,419 | |
| Filed 2020-03-31 12:17 Tx date 2020-03-30 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,400
+4,000 vol $3.60 each |
16,528 | |
| Filed 2020-03-02 12:47 Tx date 2019-12-31 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,860
+1,037 vol $7.58 each |
12,528 | |
| Filed 2019-12-22 09:13 Tx date 2019-12-18 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+200 vol |
11,491 | |
| Filed 2019-03-28 Tx date 2018-09-04 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-03-28 Tx date 2019-03-28 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$85,021
+11,291 vol $7.53 each |
11,291 | |
| Filed 2019-03-22 Tx date 2019-03-19 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$37,063
+4,509 vol $8.22 each |
9,948 | |
| Filed 2018-09-11 Tx date 2018-09-10 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$52,214
+5,439 vol $9.60 each |
5,439 | |
| Filed 2018-09-11 Tx date 2018-09-04 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-08 Tx date 2017-01-06 |
$DXD
3D Signatures Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-08 Tx date 2017-12-05 |
$DXD
3D Signatures Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,000
+50,000 vol $0.20 each |
50,000 | |
| Filed 2017-12-08 Tx date 2017-01-06 |
$DXD
3D Signatures Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-08 Tx date 2017-12-05 |
$DXD
3D Signatures Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+50,000 vol |
50,000 | |
| Filed 2017-01-13 Tx date 2017-01-06 |
$DXD
3D Signatures Inc.(Formerly Plicit Capital Corp.) |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$165,000
+220,000 vol $0.75 each |
220,000 | |
| Filed 2017-01-13 Tx date 2017-01-06 |
$DXD
3D Signatures Inc.(Formerly Plicit Capital Corp.) |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$6,398
+1,032 vol $6.20 each |
||
| Filed 2016-02-18 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$12,796
+2,064 vol $6.20 each |
9,460 | |
| Filed 2016-02-17 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$6,398
+1,032 vol $6.20 each |
8,428 | |
| Filed 2015-08-21 Tx date 2015-08-17 |
$RX
BioSyent Inc. |
van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
|
7,396 |